Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors

ανά Bloudek, Lisa M., Makenbaeva, Dinara, Eaddy, Michael
Τόπος έκδοσης Am Health Drug Benefits (2015)

Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia

ανά Campbell, David, Blazer, Marlo, Bloudek, Lisa, Brokars, John, Makenbaeva, Dinara
Τόπος έκδοσης Am Health Drug Benefits (2019)

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

ανά Deitelzweig, Steve, Amin, Alpesh, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay, Graham, John
Έκδοση 2013

Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation

ανά Kocis, Paul T., Liu, Guodong, Makenbaeva, Dinara, Trocio, Jeffrey, Velott, Diana, Trainer, JoAnn B., Abdulsattar, Younos, Molina, Marta I., Leslie, Douglas L.
Τόπος έκδοσης Drugs Real World Outcomes (2016)